<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: NORTHSTRIVE FUND II LP -->
          <cik>0002099270</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>02/05/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001704287</issuerCik>
        <issuerName>Bluejay Diagnostics, Inc.</issuerName>
        <issuerCusip>095633608</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>360 Massachusetts Avenue, Suite 203</com:street1>
          <com:city>Action</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>01720</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>11000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>11000.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>11000.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>1.55</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 11,000 shares of Bluejay Diagnostics, Inc. ("Issuer") beneficially owned by Northstrive Fund II LP, out of 708,533 shares of the Issuer's issued and outstanding shares of common stock, par value $0.0001 per share ("Common Stock") on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission ("Commission") on January 27, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <citizenshipOrOrganization>Z4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>24500.00</soleVotingPower>
        <sharedVotingPower>11000.00</sharedVotingPower>
        <soleDispositivePower>24500.00</soleDispositivePower>
        <sharedDispositivePower>11000.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>35500.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.01</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Braeden Lichti is, as of the date of this Schedule 13G, the Manager of Northstrive Fund II LP. Percentage ownership is calculated based on 35,500 shares of Issuer beneficially owned by Mr. Lichti, out of 708,533 shares of the Issuer's issued and outstanding shares of Common Stock on January 29, 2026, as reported on the Issuer's Current Report on Form 8-K filed with the Commission on January 27, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Bluejay Diagnostics, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>360 Massachusetts Avenue, Suite 203, Action, MA 01720</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by:

(i) Northstrive Fund II LP, a Delaware limited partnership; and

(ii) Braeden Lichti ("Mr. Lichti").

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>120 Newport Center Drive, Suite 250
Newport Beach, CA 92660</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Northstrive Fund II LP is a Delaware corporation. Mr. Lichti is a citizen of Canada.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information required by Item 4(a) is set forth in Rows 5-11 of the cover page for each Reporting Person and is incorporated herein by reference for each Reporting Person.</amountBeneficiallyOwned>
        <classPercent>Northstrive Fund II LP: 1.55%
Braeden Lichti: 5.01%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Northstrive Fund II LP: 0

Braeden Lichti: 24,500</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Northstrive Fund II LP: 11,000

Braeden Lichti: 11,000</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Northstrive Fund II LP: 0

Braeden Lichti: 24,500</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Northstrive Fund II LP: 11,000

Braeden Lichti: 11,000</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti, Manager</title>
        <date>02/05/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti</title>
        <date>02/05/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
